A drug used to treat cancer may also be effective in treating diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis and scleroderma. The drug stopped the production of fibrotic proteins in human cells and the development of fibrous scarring in a mouse model of fibrotic disease, according to a new study published in the journal Thorax.
